Therapy News and Research

RSS

Renowned cardiologist wins TCT 2011 Geoffrey O. Hartzler Master Clinical Operator Award

Horst Sievert, MD, PhD, a renowned interventional cardiologist, was presented the TCT 2011 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

14 Nov 2011

Maintaining normal blood glucose levels prevents long-term kidney complications

Maintaining good glucose control early in the course of type 1 diabetes could lessen the long-term risk of kidney disease, as measured by a common test of kidney function.

14 Nov 2011

Wearable defibrillator effective in preventing sudden death in people with arrhythmias

A wearable defibrillator can prevent sudden death in people with dangerous heart arrhythmias, according to research presented at the American Heart Association's Scientific Sessions 2011.

14 Nov 2011

Brazilian Ministry of Health, Bristol-Myers Squibb sign technology transfer agreement for Reyataz

Bristol-Myers Squibb Company today announced a technology transfer agreement with the Brazilian Ministry of Health to expand access to Reyataz (atazanavir sulfate) in Brazil.

13 Nov 2011

Parkinson’s disease breakthrough using stem cell therapy

Australian scientists are on the brink of a discovery that could change treatment of patients with Parkinson’s disease (PD). Transplanting stem cells could be the next big thing in PD therapy they claim.

13 Nov 2011

NeoStem third quarter revenues increase to $17.8 million

NeoStem, Inc., an international biopharmaceutical company with a focus on cell based therapeutics development, today reported third quarter results and recent progress in its business.

11 Nov 2011

Damaged mitochondria equivalent to an environmental disaster in the cell

Current thinking about Parkinson's disease is that it's a disorder of mitochondria, the energy-producing organelles inside cells, causing neurons in the brain's substantia nigra to die or become impaired.

11 Nov 2011

China Pharma third quarter revenue increases 12% to $21.0 million

China Pharma Holdings, Inc., a specialty pharmaceuticals company in China, today announced financial results for the quarter ended September 30, 2011.

11 Nov 2011

TF-CBTWeb training program for mental health professionals

Over the past six years, more than 100,000 mental health professionals - an average of nearly 1,400 per month - have registered for a free online training program that teaches an innovative therapy to help children recover from post-traumatic stress caused by abuse, violence or natural disaster.

11 Nov 2011

N-acetylcysteine plus cortisone shows promise against acute alcoholic hepatitis

Acute alcoholic hepatitis is one of the most serious forms of alcoholic liver disease, affecting individuals with chronic excessive alcohol consumption, which generally equates to more than 50 grams of alcohol per day, over a period of more than three to six months. The disease is characterized by liver failure and acute jaundice (icterus), which may induce a coma through liver failure and an ensuing death rate of between 40-45% within the first six months.

11 Nov 2011

Provectus announces data from Phase 2 PV-10 metastatic melanoma study

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at the 2011 International Melanoma Congress on November 12, 2011, during the 5th Meeting of Interdisciplinary Melanoma/Skin Cancer Centres meeting.

11 Nov 2011

First large scale trial of acupuncture for prevention of xerostomia

When given alongside radiation therapy for head and neck cancer, acupuncture has shown for the first time to reduce the debilitating side effect of xerostomia, according to new research from The University of Texas MD Anderson Cancer Center and Fudan University Shanghai Cancer Center.

11 Nov 2011

SNI receives NINDS grant to conduct clinical research studies on brain disorders

Swedish Neuroscience Institute (SNI) has been selected by the National Institutes of Health as the Pacific Northwest member of a national consortium of 25 neuroscience centers that will conduct clinical research studies on a variety of brain-related diseases.

10 Nov 2011

NYBC receives FDA approval for HEMACORD HPC-C cell therapy

The U.S. Food and Drug Administration today approved HEMACORD, the first licensed hematopoietic progenitor cells-cord (HPC-C) cell therapy.

10 Nov 2011

Drug effectively combats obesity in “couch potato” monkeys” Study

According a new study an experimental anti-cancer drug could help fight obesity. The drug chokes off the blood supply to fat cells and helped obese monkeys slim down in the experiments.

10 Nov 2011

New studies could fundamentally change medical treatment of liver cancer

Scientists at the Helmholtz Zentrum München have played a major role in two studies that could fundamentally change the medical treatment of liver cancer. Doctors are now able to determine the degree of aggressiveness of the tumour in the early stages and can thus devise an individualised treatment plan.

10 Nov 2011

Positive results from BIOTRONIK Pantera Lux Paclitaxel Releasing Balloon study presented at TCT 2011

Six-month results from the DELUX registry and 12-month results from the PEPPER study, both demonstrating excellent safety and efficacy results for the Pantera Lux Paclitaxel Releasing Balloon, were presented on Tuesday and Wednesday at the Transcatheter Cardiovascular Therapeutics (TCT 2011) conference by Dr. Ralph Toelg, MD, Segeberger Heart Center Clinic, Bad Segeberg, Germany, and Prof. Christoph Hehrlein, MD, University Medical Center, Freiburg, Germany, respectively.

10 Nov 2011

CCCBD scientist to receive 2011 V Foundation Translational Research Grant

Scientists at the Children's Center for Cancer and Blood Diseases (CCCBD) and the Keck School of Medicine of the University of Southern California, have been awarded a highly competitive translational research grant of $600,000 from The V Foundation for Cancer Research.

10 Nov 2011

Experimental drug selectively destroys blood supply of fat tissue and decreases body fat

Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine.

10 Nov 2011

Tailored anti-platelet therapy optimizes treatment for patients wtih common genetic variant

Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) have found.

10 Nov 2011

Therapy News and Research

Renowned cardiologist wins TCT 2011 Geoffrey O. Hartzler Master Clinical Operator Award

Maintaining normal blood glucose levels prevents long-term kidney complications

Wearable defibrillator effective in preventing sudden death in people with arrhythmias

Brazilian Ministry of Health, Bristol-Myers Squibb sign technology transfer agreement for Reyataz

Parkinson’s disease breakthrough using stem cell therapy

NeoStem third quarter revenues increase to $17.8 million

Damaged mitochondria equivalent to an environmental disaster in the cell

China Pharma third quarter revenue increases 12% to $21.0 million

TF-CBTWeb training program for mental health professionals

N-acetylcysteine plus cortisone shows promise against acute alcoholic hepatitis

Provectus announces data from Phase 2 PV-10 metastatic melanoma study

First large scale trial of acupuncture for prevention of xerostomia

SNI receives NINDS grant to conduct clinical research studies on brain disorders

NYBC receives FDA approval for HEMACORD HPC-C cell therapy

Drug effectively combats obesity in “couch potato” monkeys” Study

New studies could fundamentally change medical treatment of liver cancer

Positive results from BIOTRONIK Pantera Lux Paclitaxel Releasing Balloon study presented at TCT 2011

CCCBD scientist to receive 2011 V Foundation Translational Research Grant

Experimental drug selectively destroys blood supply of fat tissue and decreases body fat

Tailored anti-platelet therapy optimizes treatment for patients wtih common genetic variant

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News